Literature DB >> 19205657

Adipose tissue-skeletal muscle crosstalk: are endocannabinoids an unwanted caller?

M J Watt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19205657     DOI： 10.1007/s00125-009-1287-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  16 in total

Review 1.  Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.

Authors:  Harold E Bays; J Michael González-Campoy; George A Bray; Abbas E Kitabchi; Donald A Bergman; Alan Bruce Schorr; Helena W Rodbard; Robert R Henry
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-03

2.  Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.

Authors:  Blerina Kola; Erika Hubina; Sonia A Tucci; Tim C Kirkham; Edwin A Garcia; Sharon E Mitchell; Lynda M Williams; Simon A Hawley; D Grahame Hardie; Ashley B Grossman; Márta Korbonits
Journal:  J Biol Chem       Date:  2005-05-16       Impact factor: 5.157

3.  Obesity is associated with macrophage accumulation in adipose tissue.

Authors:  Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 4.  Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.

Authors:  Robin Christensen; Pernelle Kruse Kristensen; Else Marie Bartels; Henning Bliddal; Arne Astrup
Journal:  Lancet       Date:  2007-11-17       Impact factor: 79.321

5.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

Authors:  Daniela Cota; Giovanni Marsicano; Matthias Tschöp; Yvonne Grübler; Cornelia Flachskamm; Mirjam Schubert; Dorothee Auer; Alexander Yassouridis; Christa Thöne-Reineke; Sylvia Ortmann; Federica Tomassoni; Cristina Cervino; Enzo Nisoli; Astrid C E Linthorst; Renato Pasquali; Beat Lutz; Günter K Stalla; Uberto Pagotto
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

6.  Adipose tissue infiltration in skeletal muscle: age patterns and association with diabetes among men of African ancestry.

Authors:  Iva Miljkovic-Gacic; Christopher L Gordon; Bret H Goodpaster; Clareann H Bunker; Alan L Patrick; Lewis H Kuller; Victor W Wheeler; Rhobert W Evans; Joseph M Zmuda
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

7.  Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.

Authors:  Luc Van Gaal; Xavier Pi-Sunyer; Jean-Pierre Després; Christine McCarthy; André Scheen
Journal:  Diabetes Care       Date:  2008-02       Impact factor: 19.112

Review 8.  CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health.

Authors:  Daniela Cota
Journal:  Diabetes Metab Res Rev       Date:  2007-10       Impact factor: 4.876

Review 9.  Disordered lipid metabolism and the pathogenesis of insulin resistance.

Authors:  David B Savage; Kitt Falk Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

10.  The CB1 endocannabinoid system modulates adipocyte insulin sensitivity.

Authors:  Roja Motaghedi; Timothy E McGraw
Journal:  Obesity (Silver Spring)       Date:  2008-06-12       Impact factor: 5.002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.